BCMA x CD3 T-cell engager in a patient with penta-refractory multiple myeloma and HIV: a clinical and immunological report

被引：0
|
作者：
Cords, Leon [1 ]
Schaefers, Christoph [2 ]
Kamili, Abdulaziz [2 ]
Hoffmann, Christian [3 ,4 ]
Cichutek, Sophia [2 ]
Haag, Friedrich [5 ]
Polywka, Susanne [6 ]
Bokemeyer, Carsten [2 ]
Leypoldt, Lisa [2 ]
Alsdorf, Winfried [2 ]
zur Wiesch, Julian Schulze [1 ,7 ]
Weisel, Katja C. [2 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Infect Dis Unit, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Hematol Oncol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany
[3] ICH Study Ctr, Hamburg, Germany
[4] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Campus Kiel, Kiel, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany
[6] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany
[7] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 09期
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.3324/haematol.2023.284917
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3071 / 3077
页数：7
相关论文
共 50 条
  • [31] CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
    Xu, Yang
    Zhang, Xuzhao
    Xin, Dijia
    Zhang, Jiawei
    Wang, Luyao
    Fan, Yili
    Chen, Boxiao
    Lei, Wen
    Qiu, Xi
    Jiang, Huawei
    Xiao, Xibin
    Huang, Liansheng
    Yu, Jiandong
    Yang, Xin
    Yang, Wenjun
    Zhu, Jiangao
    Qian, Wenbin
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (01) : 23 - 34
  • [32] IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma
    Fei, Keke
    Ni, Haiqing
    Zhu, Mengjia
    Kuang, Zhihui
    Wu, Min
    Wu, Zhihai
    Wang, Feifei
    Zhou, Shuaixiang
    Jing, Hua
    Wu, Weiwei
    Wu, Dongdong
    Bai, Dongmei
    Chen, Bingliang
    CANCER LETTERS, 2022, 536
  • [33] Pharmacokinetics and Immunogenicity of Abbv-383, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific T-Cell-Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Polepally, Akshanth R.
    Biesdorf, Carla
    Uddin, Muhammad Erfan
    Boehm, Nils
    Ross, Jeremy A.
    Kumar, Shaji Kunnathu
    Voorhees, Peter M.
    D'Souza, Anita
    Weisel, Katja
    Bueno, Orlando
    Talati, Chetasi
    Menon, Rajeev M.
    BLOOD, 2023, 142
  • [34] Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
    Sangsuwannukul, Thanich
    Supimon, Kamonlapat
    Chieochansin, Thaweesak
    Choomee, Kornkan
    Sujjitjoon, Jatuporn
    Junking, Mutita
    Yenchitsomanus, Pa-Thai
    PLOS ONE, 2022, 17 (03):
  • [35] Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies
    Lefevre, Apolline
    Parra-Guillen, Zinnia P.
    Troconiz, Inaki F.
    Boetsch, Christophe
    Frances, Nicolas
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [36] A Phase 1 First-in-Human Study of Abbv-383, a BCMA x CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
    Voorhees, Peter M.
    D'Souza, Anita
    Weisel, Katja
    Hurd, David Duane
    Teipel, Raphael
    Chung, Alfred
    Rodriguez, Cesar
    Tuchman, Sascha A.
    Korde, Neha
    Safah, Hana
    Bueno, Orlando F.
    Pumford, Neil
    Rosenberg, Tanya S.
    Pothacamury, Rajvineeth Kumar
    Ross, Jeremy A.
    Polepally, Akshanth R.
    Lee, Shane
    Jin, Ziyi
    Talati, Chetasi
    Vij, Ravi
    Kumar, Shaji K.
    BLOOD, 2022, 140 : 4401 - 4404
  • [37] Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM)
    Theprungsirikul, Poy
    Yu, Mansen
    Rall, Kerri
    Matthews, Martin
    Neparidze, Natalia
    Parker, Terri L.
    Browning, Sabrina
    Anderson, Tara
    Stevens, Erica
    Foss, Francine M.
    Gowda, Lohith
    Pillai, Manoj
    Isufi, Iris
    Seropian, Stuart
    Mirza, Sayeef
    Bar, Noffar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [39] Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis
    Ralph Wäsch
    Tim Strüssmann
    Claudia Wehr
    Reinhard Marks
    Phillip T. Meyer
    Gerd Walz
    Monika Engelhardt
    Annals of Hematology, 2023, 102 : 1269 - 1270
  • [40] Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis
    Waesch, Ralph
    Struessmann, Tim
    Wehr, Claudia
    Marks, Reinhard
    Meyer, Phillip T.
    Walz, Gerd
    Engelhardt, Monika
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1269 - 1270
12345